AI governance & assurance system
The organizational system used to control consequential AI within the approved scope.
At a glance
Eligibility review is free. You pay nothing until eligibility is confirmed and an agreement is signed.
For health systems, life sciences and other organizations that build or rely on consequential AI — independent review of accountability, validation, human oversight, monitoring and lifecycle change.
501(c)(3) nonprofit · Standards published · Independent decision · Publicly verifiable

AIG evaluates the organization-level governance and assurance system for consequential AI. Other CHSPS pathways address narrower AI contexts.
Inventory, risk, validation, human oversight, monitoring, vendors, incidents and lifecycle control.
Integrity system surrounding consequential examinations and assessment decisions.
Remote proctoring, identity, administration, technology and AI-assisted monitoring.
AI tutors, feedback, instructional support and assessment-boundary controls.
Public verification identifies the entity, role profile, covered AI systems or use categories, sites or services, and explicit exclusions.
The organizational system used to control consequential AI within the approved scope.
Named systems, use categories, consequential functions, business units, services and sites.
Individual practitioners, every AI product automatically, unrelated uses, or activity outside the approved scope.
Edition 2026.1 · continuous eligibility intake · 3-year accreditation term.
Expect deeper review of design controls, data governance, validation, release criteria, model/version traceability, customer limitations, monitoring commitments, incident handling and material change.
Reviewers test documented controls against operating evidence, records, demonstrations, interviews and lifecycle tracers.
Authority, owners, competence, decision rights and management review.
System, vendor, version, intended use, owner, affected population, impact, risk and monitoring.
Purpose, users, limitations, unsupported uses and approval boundaries.
Provenance, quality, representativeness, access, privacy and lineage.
Pre-use and change-triggered analysis of foreseeable harm and residual risk.
Acceptance criteria, relevant test conditions, results, limitations and revalidation.
Qualified review, authority to challenge, override or stop, escalation and automation-bias controls.
Bias and fairness evaluation, access, complaint signals and remediation proportionate to risk.
Records sufficient to reconstruct versions, approvals, decisions and human actions.
Due diligence, contracts, evidence access, change and incident notice, and continuity.
Performance and drift signals, incident response, root cause, corrective action and effectiveness.
Material-change review, revalidation, rollback, release, retirement and preserved history.
The evidence record is tested end to end, not as a policy-only exercise.
The first eligibility and scope review is free. Formal fees begin only after CHSPS confirms the proposed scope and the agreement is signed.
Fit and preliminary scope confirmation.
After confirmed scope and signed agreement.
Balance when the formal evidence package is submitted.
AIG uses the same institutional accreditation pathway as every CHSPS program, with AI-specific evidence and tracers.
Confirm pathway fit, role profile and proposed scope.
Finalize covered entity, AI systems/use categories, services/sites, exclusions and fees.
Map CORE-100 and AIG-610 to inventory, risk, validation, oversight, monitoring and lifecycle evidence.
Review documents, records, samples, interviews, demonstrations and lifecycle tracers.
Address requirement-linked findings with objective evidence and effectiveness checks.
Decision-makers separate from technical review evaluate the complete record.
Approved scope is published and then maintained through annual reporting, material-change duties and renewal.
External evaluation beyond an organization's own responsible-AI declarations.
Governance from inventory and validation through monitoring, change and retirement.
Evidence that consequential use remains subject to defined human authority, challenge and escalation.
Stakeholders can verify exactly which organization, role and AI scope CHSPS reviewed.
Use HSAI for consequential assessment integrity, REA for remote examination administration, and ALT for learner-facing AI. AIG is the organization-level AI governance pathway.
AI systems change quickly. Accredited governance must remain current, traceable and effective throughout the term.
Target renewal submission: 6 months before expiration. A new product, site or AI use is not automatically within accredited scope.
Step-by-step evidence map and pre-submission checklist.
Download guide →Inventory, risk, validation, monitoring, incident/CAPA and vendor templates.
Open toolkit →Walk through AIG-610 readiness without pre-approval of evidence.
Open preparation center →Impartiality safeguard: preparation materials explain requirements and provide general tools. They do not pre-approve evidence, guarantee an outcome or influence accreditation decision-makers.
Normative AIG requirements, role applicability and evidence expectations are controlled in the published specialty standard and used with CHSPS-CORE-100.
$5,500 for the initial specialty review: the $1,250 application fee when you sign the applicant agreement, then the $4,250 review balance when you submit evidence. After that, $1,500 a year and a $3,500 renewal review every 3 years. A concurrent additional specialty scope in the same organization is $2,750. The eligibility review is free.
The free eligibility review targets a written outcome within 10 business days after a complete inquiry. CHSPS does not publish a single planning target for this pathway; the review timeline is stated in writing at scope confirmation, before you pay anything.
Nothing to upload. Step 1 asks only for your name, email and organization; the rest of the form covers scope, operating status and readiness, in about 5 minutes. Formal evidence comes after the agreement is signed: AI inventory, risk, validation, human oversight, monitoring and lifecycle evidence.
Yes. CHSPS is a United States–based 501(c)(3) nonprofit; organizations in any country may apply.
Every eligibility review ends in a written outcome: Eligible, Potentially Eligible — Additional Information Required, or Not Eligible, with the specific thresholds not yet met. There is no charge for the review, and if a different CHSPS pathway fits better, the review says so.
No. Only AI systems, use categories, functions, sites or services explicitly included in the approved scope are represented as accredited.
Tell us what consequential AI your organization develops, provides, deploys or relies on. We will confirm pathway fit, role profile and proposed scope in writing before application fees begin.
CHSPS is an independent accreditor. CHSPS is a United States–based 501(c)(3) nonprofit; organizations in any country may apply.